Literature DB >> 30479200

Incident-to Billing for Pharmacists.

Eric Dietrich1, John G Gums1.   

Abstract

The inclusion of pharmacists on care teams has been shown to improve clinical and economic health outcomes. However, a significant barrier to the widespread incorporation of pharmacists into care teams is the ability to financially support the salary of the pharmacist. A mechanism to improve the ability of pharmacists to generate clinical revenue already exists in the form of incident-to billing, although there remains considerable uncertainty regarding the criteria for incident-to billing and specifically how pharmacists can use this model to capture revenue for clinical services. In this article, we discuss incident-to billing criteria as it pertains to outpatient clinics, common misconceptions related to incident-to billing, and how clinical pharmacists may use this mechanism to generate revenue for the clinical services they provide. DISCLOSURES: This work was not supported by any funding source. The authors have no relevant conflicts of interest to disclose.

Entities:  

Mesh:

Year:  2018        PMID: 30479200     DOI: 10.18553/jmcp.2018.24.12.1273

Source DB:  PubMed          Journal:  J Manag Care Spec Pharm


  3 in total

1.  Ambulatory care practice in the COVID-19 era: Redesigning clinical services and experiential learning.

Authors:  Insaf Mohammad; Helen D Berlie; Melissa Lipari; Amber Lanae Martirosov; Andrea A Duong; Maggie Faraj; Opal Bacon; Candice L Garwood
Journal:  J Am Coll Clin Pharm       Date:  2020-07-07

2.  Community Pharmacists' Perceptions of Patient Care Services within an Enhanced Service Network.

Authors:  Christopher J Daly; Bryan Quinn; Anna Mak; David M Jacobs
Journal:  Pharmacy (Basel)       Date:  2020-09-16

3.  Impact of an ambulatory care pharmacist on provider relative value units in a rural clinic.

Authors:  Christina E DeRemer; Nicole A Perez; Kimberly Middleton; Jason Konopack; Eric Dietrich
Journal:  Explor Res Clin Soc Pharm       Date:  2021-12-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.